These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
218 related articles for article (PubMed ID: 17239348)
1. Inhibition of lipid A-mediated type I interferon induction by bactericidal/permeability-increasing protein (BPI). Azuma M; Matsuo A; Fujimoto Y; Fukase K; Hazeki K; Hazeki O; Matsumoto M; Seya T Biochem Biophys Res Commun; 2007 Mar; 354(2):574-8. PubMed ID: 17239348 [TBL] [Abstract][Full Text] [Related]
2. TICAM-1 and TICAM-2: toll-like receptor adapters that participate in induction of type 1 interferons. Seya T; Oshiumi H; Sasai M; Akazawa T; Matsumoto M Int J Biochem Cell Biol; 2005 Mar; 37(3):524-9. PubMed ID: 15618008 [TBL] [Abstract][Full Text] [Related]
3. Antagonistic effects of lipopolysaccharide binding protein and bactericidal/permeability-increasing protein on lipopolysaccharide-induced cytokine release by mononuclear phagocytes. Competition for binding to lipopolysaccharide. Dentener MA; Von Asmuth EJ; Francot GJ; Marra MN; Buurman WA J Immunol; 1993 Oct; 151(8):4258-65. PubMed ID: 8409400 [TBL] [Abstract][Full Text] [Related]
4. Differential regulation of lipopolysaccharide (LPS) activation pathways in mouse macrophages by LPS-binding proteins. Amura CR; Kamei T; Ito N; Soares MJ; Morrison DC J Immunol; 1998 Sep; 161(5):2552-60. PubMed ID: 9725255 [TBL] [Abstract][Full Text] [Related]
5. Interchangeable endotoxin-binding domains in proteins with opposite lipopolysaccharide-dependent activities. Schumann RR; Lamping N; Hoess A J Immunol; 1997 Dec; 159(11):5599-605. PubMed ID: 9548502 [TBL] [Abstract][Full Text] [Related]
6. The role of bactericidal/permeability-increasing protein as a natural inhibitor of bacterial endotoxin. Marra MN; Wilde CG; Collins MS; Snable JL; Thornton MB; Scott RW J Immunol; 1992 Jan; 148(2):532-7. PubMed ID: 1729370 [TBL] [Abstract][Full Text] [Related]
7. The BPI/LBP family of proteins: a structural analysis of conserved regions. Beamer LJ; Carroll SF; Eisenberg D Protein Sci; 1998 Apr; 7(4):906-14. PubMed ID: 9568897 [TBL] [Abstract][Full Text] [Related]
8. Plasma levels of bactericidal/permeability-increasing protein (BPI) and lipopolysaccharide-binding protein (LBP) during hemodialysis. Schindler R; Marra MN; McKelligon BM; Lonnemann G; Schulzeck P; Schulze M; Oppermann M; Shaldon S Clin Nephrol; 1993 Dec; 40(6):346-51. PubMed ID: 7507806 [TBL] [Abstract][Full Text] [Related]
9. Soluble G protein of respiratory syncytial virus inhibits Toll-like receptor 3/4-mediated IFN-beta induction. Shingai M; Azuma M; Ebihara T; Sasai M; Funami K; Ayata M; Ogura H; Tsutsumi H; Matsumoto M; Seya T Int Immunol; 2008 Sep; 20(9):1169-80. PubMed ID: 18611945 [TBL] [Abstract][Full Text] [Related]
10. Bactericidal/permeability-increasing protein has endotoxin-neutralizing activity. Marra MN; Wilde CG; Griffith JE; Snable JL; Scott RW J Immunol; 1990 Jan; 144(2):662-6. PubMed ID: 2295804 [TBL] [Abstract][Full Text] [Related]
11. The role of lipopolysaccharides in the action of the bactericidal/permeability-increasing neutrophil protein on the bacterial envelope. Weiss J; Muello K; Victor M; Elsbach P J Immunol; 1984 Jun; 132(6):3109-15. PubMed ID: 6373924 [TBL] [Abstract][Full Text] [Related]
12. Stable transduction of bovine TLR4 and bovine MD-2 into LPS-nonresponsive cells and soluble CD14 promote the ability to respond to LPS. Sauter KS; Brcic M; Franchini M; Jungi TW Vet Immunol Immunopathol; 2007 Jul; 118(1-2):92-104. PubMed ID: 17559944 [TBL] [Abstract][Full Text] [Related]
13. Human granulocytes express a 55-kDa lipopolysaccharide-binding protein on the cell surface that is identical to the bactericidal/permeability-increasing protein. Weersink AJ; van Kessel KP; van den Tol ME; van Strijp JA; Torensma R; Verhoef J; Elsbach P; Weiss J J Immunol; 1993 Jan; 150(1):253-63. PubMed ID: 7678030 [TBL] [Abstract][Full Text] [Related]
14. Bacterial lipopolysaccharide induces increased expression of toll-like receptor (TLR) 4 and downstream TLR signaling molecules in bovine mammary epithelial cells. Ibeagha-Awemu EM; Lee JW; Ibeagha AE; Bannerman DD; Paape MJ; Zhao X Vet Res; 2008; 39(2):11. PubMed ID: 18096120 [TBL] [Abstract][Full Text] [Related]
15. Structural requirements for intracellular processing and sorting of bactericidal/permeability-increasing protein (BPI): comparison with lipopolysaccharide-binding protein. Bülow E; Gullberg U; Olsson I J Leukoc Biol; 2000 Nov; 68(5):669-78. PubMed ID: 11073106 [TBL] [Abstract][Full Text] [Related]
16. Identification and expression analysis on bactericidal permeability-increasing protein (BPI)/lipopolysaccharide-binding protein (LBP) of ark shell, Scapharca broughtonii. Mao Y; Zhou C; Zhu L; Huang Y; Yan T; Fang J; Zhu W Fish Shellfish Immunol; 2013 Sep; 35(3):642-52. PubMed ID: 23742867 [TBL] [Abstract][Full Text] [Related]
17. The genomic organization of the genes for human lipopolysaccharide binding protein (LBP) and bactericidal permeability increasing protein (BPI) is highly conserved. Hubacek JA; Büchler C; Aslanidis C; Schmitz G Biochem Biophys Res Commun; 1997 Jul; 236(2):427-30. PubMed ID: 9240454 [TBL] [Abstract][Full Text] [Related]
18. Antibacterial proteins of granulocytes differ in interaction with endotoxin. Comparison of bactericidal/permeability-increasing protein, p15s, and defensins. Levy O; Ooi CE; Elsbach P; Doerfler ME; Lehrer RI; Weiss J J Immunol; 1995 May; 154(10):5403-10. PubMed ID: 7730641 [TBL] [Abstract][Full Text] [Related]
19. mRNA expression patterns of the BPI/LBP molecule in the Atlantic cod (Gadus morhua L.). Solstad T; Stenvik J; Jørgensen TØ Fish Shellfish Immunol; 2007 Aug; 23(2):260-71. PubMed ID: 17442589 [TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of truncated human lipopolysaccharide-binding protein in Escherichia coli. Kohara J; Tsuneyoshi N; Gauchat JF; Kimoto M; Fukudome K Protein Expr Purif; 2006 Oct; 49(2):276-83. PubMed ID: 16839777 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]